Abstract:To the Editor: By controlling multiple confounding factors, the important article of Qureshi and colleagues implies that a causal link exists between posttraumatic stress disorder (PTSD) and late-life dementia.1,2 This letter reviews the authors' response to it and explores possible cerebral functional and structural evidence to support a relationship between the two diseases. Establishing the relationship between PTSD and dementia heavily relies on cerebral functional abnormalities and cerebral atrophy. It would provide an improvement in clinic decision-making, such as early prevention, better prediction of progress, and prognosis in dementia. However, mainly based on a twin study,3 a recent opinion claimed that no causal relationship seemed to exist between PTSD and dementia.4 Because the opinion and the article of Qureshi and colleagues ignore the PTSD-induced functional abnormalities that are commonly accepted and some debate still exists regarding the structural studies, it is important to separate the two abnormalities and provide some critical opinions and experiments related to the twin study to reveal the underlying link between the two diseases. Much previous research has found robust evidence for PTSD-induced functional abnormalities, including hyperresponsive amygdala, hypoactive medial prefrontal cortex (MPFC), and anterior cingulate cortex (ACC) dysfunction.5,6 Emotional Stroop research on PTSD first highlighted diminished medial prefrontal and anterior cingulate activation, which neuroimaging research on patients with PTSD exposed to trauma-related pictures, sounds, or traumatic imagery scripts further supported. Because abnormalities of these areas can predict the onset and progress of dementia, these studies suggest that a link exists between the two diseases. Poorer functional activity is not always associated with lower volume that is closely related to dementia, so more evidence from structural imaging studies is needed, but some debate still exists on PTSD-induced neurotoxicity, and the limitations of these experiments are obvious. For example, genetic studies require large sample sizes to detect small to medium gene effects, but subject numbers in twin neuroimaging studies are always small.7 Moreover, the present main drawback of voxel-based morphometry analysis is the potential poor sensitivity to detect regional changes. A great number of animal studies strongly support the hypothesis that stress can decrease dendritic branching and neurogenesis in MPFC volume and damage hippocampal formation.8 MPFC and pregenual ACC are highly interconnected with the amygdala, and structural or functional abnormalities in these regions have been reported to markedly impair fear extinction in human. Some researchers emphasize that not only has research in humans found that ACC volumes in PTSD are smaller than in trauma-exposed individuals without PTSD, but has also found that ACC volume correlates with severity of PTSD symptoms.5 One of the most important types of genetic neuroimaging studies in human is twin studies. One twin study revealed that combat veterans with PTSD and their identical twins who did not have PTSD had smaller hippocampus than combat veterans without PTSD, suggesting that a small hippocampus is a risk factor for rather than a result of PTSD.2 Nevertheless, some scientists criticized the twin study and called for a replication of this research. The same group reported inconsistent results in different papers and the reason is unclear. In addition, a small hippocampus was not an extraordinarily strong predictor for the enormous overlap in the volume data. They believed that hippocampus volume and stress could affect each other.9 In contrast to the previous twin study, another twin study emphasized that there was no evidence of regional differences related to genetic risk for PTSD and that most regional changes correlated with PTSD. Meanwhile, it suggested that pregenual ACC is also significantly associated with PTSD and combat exposure.10 In conclusion, correlation, even post hoc, does not equal causation, but a large number of consistent studies indicate that causation is likely to exist between the two diseases. Further genetic neuroimaging studies and pathological research on the frontal amygdala circuit and hippocampus shall contribute to the causation. Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper. Author Contributions: The first author wrote the manuscript, and others took part in design, study concept, and preparation. Sponsor's Role: None.

Risk of Neuropsychiatric Symptoms Among People Who Develop Cognitive Impairment With and Without a History of Post-traumatic Stress Disorder

Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women

PTSD IS ASSOCIATED WITH LONGITUDINAL CHANGES IN DOMAIN-SPECIFIC COGNITIVE FUNCTION IN OLDER ADULTS

Post-traumatic stress disorder symptom remission and cognition in a large cohort of civilian women

Associations of Post-Traumatic Stress Disorder and Objective Subtle Cognitive Difficulties in Cognitively Unimpaired Older Veterans

Co-Occurring Mental and Physical Health Conditions Among Older Adults With and Without Post-traumatic Stress Disorder: A Case Control Study

FUNCTIONAL ABNORMALITIES AND CEREBRAL ATROPHY IN POSTTRAUMATIC STRESS DISORDER AND DEMENTIA: IS THERE A CAUSAL LINK BETWEEN THE TWO DISEASES?

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

Investigating neural markers of Alzheimer's disease in posttraumatic stress disorder using machine learning algorithms and magnetic resonance imaging

Biomarkers associated with cognitive impairment in post-traumatic stress disorder: a systematic review of current evidence

0928 Sleep, Mediating the Risk of Cognitive Impairment in Post-traumatic Stress Disorder via Noradrenalin Dysregulation

Neuropsychiatric symptoms of dementia in those with and without a recorded history of psychological trauma: A comparative study from an Australian dementia support service

Posttraumatic Stress Disorder is a Stronger Predictor of Long-Term Neurobehavioral Outcomes Than Traumatic Brain Injury Severity

Quantifying the neuropsychiatric symptoms in post-acute sequelae of COVID-19 (PASC) using the NIH Toolbox ® and PROMIS

PTSD moderates the association between subjective cognitive decline and Alzheimer's disease biomarkers in older veterans

Estimating the risk of PTSD in recent trauma survivors: results of the International Consortium to Predict PTSD (ICPP)

Assessment of brain age in posttraumatic stress disorder: Findings from the ENIGMA PTSD and brain age working groups

Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19

Neurobehavioral moderators of post-traumatic stress disorder (PTSD) trajectories: study protocol of a prospective MRI study of recent trauma survivors

Associations of posttraumatic stress disorder symptoms with amyloid burden in cognitively normal older adults

0119 Symptoms of Post-Traumatic Stress Disorder and Self-Rated Multidimensional Sleep Health